186 related articles for article (PubMed ID: 12887267)
1. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
2. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
3. Summaries for patients. Treatment for resistant HIV-1 infection.
Ann Intern Med; 2003 Sep; 139(5 Pt 1):I22. PubMed ID: 12965954
[No Abstract] [Full Text] [Related]
4. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
Squires K; Pozniak AL; Pierone G; Steinhart CR; Berger D; Bellos NC; Becker SL; Wulfsohn M; Miller MD; Toole JJ; Coakley DF; Cheng A;
Ann Intern Med; 2003 Sep; 139(5 Pt 1):313-20. PubMed ID: 12965939
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
7. Tenofovir disoproxil fumarate.
Gallant JE; Deresinski S
Clin Infect Dis; 2003 Oct; 37(7):944-50. PubMed ID: 13130407
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
Antoniou T; Park-Wyllie LY; Tseng AL
Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458
[TBL] [Abstract][Full Text] [Related]
9. The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1.
McColl DJ; Miller MD
J Antimicrob Chemother; 2003 Feb; 51(2):219-23. PubMed ID: 12562684
[No Abstract] [Full Text] [Related]
10. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
[No Abstract] [Full Text] [Related]
11. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
[No Abstract] [Full Text] [Related]
12. Renal safety of tenofovir in HIV treatment-experienced patients.
Izzedine H; Isnard-Bagnis C; Hulot JS; Vittecoq D; Cheng A; Jais CK; Launay-Vacher V; Deray G
AIDS; 2004 Apr; 18(7):1074-6. PubMed ID: 15096814
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir disoproxil fumarate (Viread).
Porche DJ
J Assoc Nurses AIDS Care; 2002; 13(3):100-2. PubMed ID: 12064015
[TBL] [Abstract][Full Text] [Related]
14. Tenacious tenofovir struts its stuff in a virtual ICAAC.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):9-11. PubMed ID: 11727571
[No Abstract] [Full Text] [Related]
15. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
[No Abstract] [Full Text] [Related]
16. Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.
Coca S; Perazella MA
Am J Med Sci; 2002 Dec; 324(6):342-4. PubMed ID: 12495304
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir, equivalence, and noninferiority.
Parienti JJ
JAMA; 2004 Oct; 292(16):1951; author reply 1951-2. PubMed ID: 15507576
[No Abstract] [Full Text] [Related]
18. Tenofovir ready for approval.
AIDS Patient Care STDS; 2001 Jul; 15(7):399. PubMed ID: 11483167
[No Abstract] [Full Text] [Related]
19. Renal lesions in HIV-1-positive patient treated with tenofovir.
Créput C; Gonzalez-Canali G; Hill G; Piketty C; Kazatchkine M; Nochy D
AIDS; 2003 Apr; 17(6):935-7. PubMed ID: 12660548
[No Abstract] [Full Text] [Related]
20. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
